PT-141 is utilized in various research domains, including:
Neuroendocrine Studies: Investigating the peptide’s role in modulating hormonal pathways related to sexual behavior.
Melanocortin Receptor Research: Studying the activation and signaling mechanisms of MC3R and MC4R receptors.
Sexual Function Research: Exploring potential therapeutic applications for conditions like hypoactive sexual desire disorder (HSDD) and erectile dysfunction (ED)
$55.00
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide and a potent agonist of melanocortin receptors, primarily MC3R and MC4R. Derived from the α-melanocyte-stimulating hormone (α-MSH), PT-141 is extensively studied for its role in modulating neuroendocrine functions, particularly those related to sexual behavior and arousal mechanisms.
Unlike peripheral agents that target vascular pathways, PT-141 exerts its effects centrally by activating specific receptors in the hypothalamus, thereby influencing sexual desire and arousal through neural pathways
Reviews
There are no reviews yet.